Discovery of a Potent Nicotinic Acid Receptor Agonist for the Treatment of Dyslipidemia
作者:Jun Qin、Ashwin Rao、Xiao Chen、Xiaohong Zhu、Zhidan Liu、Xianhai Huang、Sylvia Degrado、Ying Huang、Dong Xiao、Robert Aslanian、Boonlert Cheewatrakoolpong、Hongtao Zhang、Scott Greenfeder、Constance Farley、John Cook、Stan Kurowski、Qiu Li、Margaret van Heek、Madhu Chintala、Ganfeng Wang、Yunsheng Hsieh、Fangbiao Li、Anandan Palani
DOI:10.1021/ml100251u
日期:2011.2.10
cutaneous vasodilation “flushing” on the upper body and face. We discovered a pyranopyrimidinedione series to be nicotinic acid receptor agonists. A potent nicotinic acid receptor agonist from this series 5-(3-cyclopropylpropyl)-2-(difluoromethyl)-3H-pyrano[2,3-d]pyrimidine-4,7-dione}with reduced flushing side effect in dogs was identified.
数十年来,烟酸已在临床上用于控制血清脂蛋白。烟酸降低极低密度脂蛋白(VLDL)-胆固醇、低密度脂蛋白(LDL)-胆固醇和脂蛋白-a(LPa),对升高高密度脂蛋白(HDL)-胆固醇也有效。然而,烟酸在临床使用中具有多种副作用。最显着的是上半身和面部强烈的皮肤血管舒张“潮红”。我们发现吡喃并嘧啶二酮系列是烟酸受体激动剂。该系列中一种有效的烟酸受体激动剂 5-(3-cyclopropylpropyl)-2-(difluoromethyl)-3 H- pyrano[2,3 - d ]pyrimidine-4,7-dione},可减少狗的潮红副作用被识别。